Jeffrey A Lieberman Selected Research

Haloperidol (Haldol)

1/2013	Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type.
4/2012	Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
1/2012	Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness.
6/2011	Aripiprazole versus haloperidol treatment in early-stage schizophrenia.
5/2010	A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
4/2010	Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
5/2009	Time-lapse mapping of cortical changes in schizophrenia with different treatments.
10/2006	Insight in first-episode psychosis.
1/2006	Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis.
12/2005	Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Lieberman Research Topics

Disease

194	Schizophrenia (Dementia Praecox) 01/2022 - 02/2002
61	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 02/2002
44	Weight Gain 01/2020 - 02/2002
25	Tardive Dyskinesia 01/2021 - 08/2004
8	Psychomotor Agitation (Akathisia) 10/2019 - 08/2003
7	Obesity 01/2015 - 08/2004
6	Dyskinesias (Dyskinesia) 10/2020 - 11/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 12/2005
6	Cognitive Dysfunction 01/2020 - 01/2004
6	Treatment-Resistant Schizophrenia 01/2019 - 10/2002
6	Body Weight (Weight, Body) 01/2018 - 01/2005
6	Alzheimer Disease (Alzheimer's Disease) 12/2010 - 10/2006
5	Movement Disorders (Movement Disorder) 01/2021 - 05/2009
5	Bipolar Disorder (Manic Depressive Psychosis) 05/2010 - 01/2004
5	Substance-Related Disorders (Drug Abuse) 03/2008 - 02/2004
4	Inflammation (Inflammations) 01/2019 - 12/2009
4	Mood Disorders (Mood Disorder) 01/2016 - 03/2003
4	Weight Loss (Weight Reduction) 09/2013 - 09/2005
4	Parkinsonian Disorders (Parkinsonism) 02/2010 - 08/2003
3	Chronic Disease (Chronic Diseases) 01/2021 - 10/2009
3	Agranulocytosis (Granulocytopenia) 01/2019 - 04/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2010 - 01/2004
3	Hyperglycemia 07/2009 - 09/2002
2	Atrophy 01/2020 - 04/2013
2	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2019 - 07/2007
2	Insulin Resistance 01/2018 - 01/2005
2	Disease Progression 01/2017 - 05/2009
2	Drug-Related Side Effects and Adverse Reactions 09/2014 - 02/2010
2	Overweight 09/2013 - 07/2009
2	Eosinophilia 11/2011 - 04/2006
2	Hallucinations (Hallucination) 01/2011 - 10/2005
2	Neurobehavioral Manifestations 10/2009 - 07/2009
2	Coronary Disease (Coronary Heart Disease) 10/2008 - 12/2005
2	Hyperlipidemias (Hyperlipidemia) 09/2006 - 08/2004
2	Hypertension (High Blood Pressure) 09/2006 - 12/2005

Drug/Important Bio-Agent (IBA)

150	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 02/2002
58	Olanzapine (Zyprexa)FDA Link 01/2018 - 02/2002
45	Clozapine (Clozaril)FDA LinkGeneric 01/2019 - 02/2002
35	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2015 - 02/2002
22	Haloperidol (Haldol)FDA LinkGeneric 01/2013 - 02/2002
16	Quetiapine Fumarate (Seroquel)FDA Link 05/2013 - 04/2006
15	Pharmaceutical PreparationsIBA 01/2021 - 01/2004
13	Glutamic Acid (Glutamate)FDA Link 01/2022 - 02/2003
12	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2004
11	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2003
10	ziprasidone (Geodon)FDA Link 06/2012 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2004
7	Perphenazine (Trilafon)FDA LinkGeneric 01/2011 - 09/2005
5	Triglycerides (Triacylglycerol)IBA 10/2019 - 01/2005
5	LipidsIBA 01/2018 - 01/2005
5	ProlactinIBA 01/2011 - 01/2004
4	Biological ProductsIBA 01/2022 - 06/2006
4	Insulin (Novolin)FDA Link 01/2018 - 01/2005
4	Molindone (Molindone Hydrochloride)FDA Link 05/2012 - 08/2007
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2009 - 08/2004
4	NeurosteroidsIBA 07/2009 - 06/2004
4	CholesterolIBA 11/2008 - 02/2003
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 10/2009
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 05/2010
3	EnzymesIBA 10/2020 - 11/2005
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 02/2003
3	Protons (Proton)IBA 01/2020 - 11/2005
3	N-Methylaspartate (NMDA)IBA 01/2019 - 11/2006
3	Chlorpromazine (Thorazine)FDA Link 01/2019 - 05/2003
3	Amphetamine (Amfetamine)FDA LinkGeneric 04/2015 - 12/2004
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015 - 05/2009
3	Peptides (Polypeptides)IBA 02/2013 - 02/2004
3	Aripiprazole (Abilify)FDA Link 06/2012 - 01/2004
3	HDL CholesterolIBA 09/2011 - 12/2005
3	PregnenoloneIBA 07/2009 - 06/2006
3	Pregnanolone (Allopregnanolone)IBA 12/2006 - 06/2004
2	Illicit Drugs (Recreational Drugs)IBA 02/2021 - 03/2008
2	Cholinergic ReceptorsIBA 01/2021 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 01/2019
2	Ketamine FDA LinkGeneric 10/2020 - 04/2013
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2020 - 08/2012
2	LeptinIBA 01/2020 - 01/2005
2	lumateperoneIBA 01/2020 - 01/2016
2	Neuregulin-1 (Neuregulin 1)IBA 01/2019 - 10/2008
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2019 - 09/2014
2	Hormones (Hormone)IBA 01/2019 - 01/2018
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019 - 05/2013
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 09/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2015
2	Saline SolutionIBA 01/2018 - 01/2015
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2016 - 04/2010
2	dihydrexidineIBA 01/2016 - 01/2015
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 10/2002
2	N-acetylaspartate (N-acetyl aspartate)IBA 06/2013 - 11/2005
2	Oxytocin (Pitocin)FDA LinkGeneric 09/2011 - 07/2010
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2010 - 06/2010
2	AntioxidantsIBA 12/2009 - 11/2005
2	Dehydroepiandrosterone (DHEA)IBA 08/2008 - 06/2006
2	Cocaine (Cocaine HCl)IBA 08/2006 - 02/2004

Therapy/Procedure

10	Therapeutics 01/2019 - 01/2005
5	Drug Therapy (Chemotherapy) 02/2017 - 02/2006
4	Duration of Therapy 01/2018 - 12/2005
2	Secondary Prevention 01/2021 - 01/2019
2	Aftercare (After-Treatment) 03/2008 - 10/2002